Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

State-of-the-art strategies for targeting protein–protein interactions by small-molecule inhibitors
Chunquan Sheng, Guoqiang Dong, Zhenyuan Miao, et al.
Chemical Society Reviews (2015) Vol. 44, Iss. 22, pp. 8238-8259
Closed Access | Times Cited: 148

Showing 76-100 of 148 citing articles:

Small Molecules as Toll-like Receptor 4 Modulators Drug and In-House Computational Repurposing
Lucía Pérez-Regidor, Joan Guzman‐Caldentey, Nils Oberhauser, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2326-2326
Open Access | Times Cited: 11
Structural insights into the biochemical mechanism of the E2/E3 hybrid enzyme UBE2O
Hao Huang, Wenning Zhu, Bin Huang, et al.
Structure (2024)
Closed Access | Times Cited: 2
Investigation of Hot Spot Region in XIAP Inhibitor Binding Site by Fragment Molecular Orbital Method
Hocheol Lim, Xuemei Jin, Jongwan Kim, et al.
Computational and Structural Biotechnology Journal (2019) Vol. 17, pp. 1217-1225
Open Access | Times Cited: 17
Therapeutic perspectives of heat shock proteins and their protein-protein interactions in myocardial infarction
Junxuan Wu, Sixuan Chen, Yuntao Liu, et al.
Pharmacological Research (2020) Vol. 160, pp. 105162-105162
Closed Access | Times Cited: 16
In Silico Identification and Evaluation of Natural Products as Potential Tumor Necrosis Factor Function Inhibitors Using Advanced Enalos Asclepios KNIME Nodes
Dimitra Papadopoulou, Antonios Drakopoulos, Panagiotis Lagarias, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10220-10220
Open Access | Times Cited: 13
Computational Tools and Strategies to Develop Peptide-Based Inhibitors of Protein-Protein Interactions
Maxence Delaunay, Tâp Ha‐Duong
Methods in molecular biology (2021), pp. 205-230
Closed Access | Times Cited: 13
Medicinal Chemistry Strategies for the Development of Inhibitors Disrupting β-Catenin’s Interactions with Its Nuclear Partners
Hao Zhang, Chenglong Liu, Di Zhu, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 1-31
Closed Access | Times Cited: 10
Inhibition of HSP90 sensitizes a novel Raf/ERK dual inhibitor CY-9d in triple-negative breast cancer cells
Yujuan Chen, Xiaoyun Wang, Chuan Ping CAO, et al.
Oncotarget (2017) Vol. 8, Iss. 61, pp. 104193-104205
Open Access | Times Cited: 16
Glutamine Synthetase Drugability beyond Its Active Site: Exploring Oligomerization Interfaces and Pockets
Cátia Moreira, Maria J. Ramos, Pedro Alexandrino Fernandes
Molecules (2016) Vol. 21, Iss. 8, pp. 1028-1028
Open Access | Times Cited: 13
PPI Modulators of E6 as Potential Targeted Therapeutics for Cervical Cancer: Progress and Challenges in Targeting E6
Lennox Chitsike, Penelope J. Duerksen-Hughes
Molecules (2021) Vol. 26, Iss. 10, pp. 3004-3004
Open Access | Times Cited: 12
Natural products used as a chemical library for protein–protein interaction targeted drug discovery
Xuemei Jin, Kyungro Lee, Nam Hee Kim, et al.
Journal of Molecular Graphics and Modelling (2017) Vol. 79, pp. 46-58
Closed Access | Times Cited: 13
Mapping Protein–Protein Interactions of the Resistance-Related Bacterial Zeta Toxin–Epsilon Antitoxin Complex (ε2ζ2) with High Affinity Peptide Ligands Using Fluorescence Polarization
María Isabel Fernández‐Bachiller, Iwona Brzozowska, Norbert Odolczyk, et al.
Toxins (2016) Vol. 8, Iss. 7, pp. 222-222
Open Access | Times Cited: 12
Network Analysis Identifies Drug Targets and Small Molecules to Modulate Apoptosis Resistant Cancers
Samreen Fathima, Swati Sinha, Sainitin Donakonda
Cancers (2021) Vol. 13, Iss. 4, pp. 851-851
Open Access | Times Cited: 11
Computational design of cyclic peptides to inhibit protein-peptide interactions
Maxence Delaunay, Tâp Ha‐Duong
Biophysical Chemistry (2023) Vol. 296, pp. 106987-106987
Closed Access | Times Cited: 4
Solid-phase parallel synthesis of 1,3,4-oxadiazole based peptidomimetic library as a potential modulator of protein-protein interactions
Aizhan Abdildinova, Seung‐Ju Yang, Yong-Dae Gong
Tetrahedron (2017) Vol. 74, Iss. 6, pp. 684-691
Closed Access | Times Cited: 12
Small molecule–based targeting of TTD-A dimerization to control TFIIH transcriptional activity represents a potential strategy for anticancer therapy
Virginie Gervais, Isabelle Müller, Pierre‐Olivier Mari, et al.
Journal of Biological Chemistry (2018) Vol. 293, Iss. 39, pp. 14974-14988
Open Access | Times Cited: 12
Fragment‐Based Protein–Protein Interaction Antagonists of a Viral Dimeric Protease
Jonathan E. Gable, Gregory M. Lee, Timothy M. Acker, et al.
ChemMedChem (2016) Vol. 11, Iss. 8, pp. 862-869
Open Access | Times Cited: 11
Synthesis of Three‐Dimensional (Di)Azatricyclododecene Scaffold and Its Application to Peptidomimetics
Kohei Umedera, Taiki Morita, Atsushi Yoshimori, et al.
Chemistry - A European Journal (2021) Vol. 27, Iss. 46, pp. 11888-11894
Closed Access | Times Cited: 10
Exploring the chemical space of protein–protein interaction inhibitors through machine learning
Jiwon Choi, Jun Seop Yun, Hye‐Eun Song, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 10
Abiotic Synthetic Antibodies to Target a Specific Protein Domain and Inhibit Its Function
Qiaolian Cheng, Xiaoyang Yu, Zhouxuan Xiong, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 17, pp. 19178-19191
Closed Access | Times Cited: 7
A DNA Force Circuit for Exploring Protein‐Protein Interactions at the Single‐Molecule Level†
Kangkang Ma, Luoan Xiong, Zhuofei Wang, et al.
Chinese Journal of Chemistry (2024) Vol. 42, Iss. 13, pp. 1456-1464
Closed Access | Times Cited: 1
Production of marine-derived bioactive peptide molecules for industrial applications: A reverse engineering approach
Akash J Surwase, Narsinh L. Thakur
Biotechnology Advances (2024) Vol. 77, pp. 108449-108449
Closed Access | Times Cited: 1
Bornylimidazo[1,5‑a]pyridin-3-ylidene allylic Pd catalyst with optimal electronic and steric properties for synthesis of 3,3’-disubstituted oxindoles
Kun Wang, Tianxue Gong, Yaohuang Huang, et al.
Chinese Chemical Letters (2024), pp. 110539-110539
Closed Access | Times Cited: 1
A small-molecule inhibitor targeting the AURKC-IκBα interaction decreases transformed growth of MDA-MB-231 breast cancer cells
Eun Hee Han, Jin‐Young Min, Shin-Ae Yoo, et al.
Oncotarget (2017) Vol. 8, Iss. 41, pp. 69691-69708
Open Access | Times Cited: 10
Monte Carlo simulations using PELE to identify a protein–protein inhibitor binding site and pose
Lucía Díaz, Daniel Soler, Gary Tresadern, et al.
RSC Advances (2020) Vol. 10, Iss. 12, pp. 7058-7064
Open Access | Times Cited: 9

Scroll to top